Comment Letters

  • Dear State of California Government Operations Agency: The Medical Imaging & Technology Alliance (MITA) has been actively engaged in providing comments for changes in the 2016 California Building Code, Title 24. We are offering the following comments with respect to the Office of Statewide Health Planning and Development (OSHPD) 04/15: California Administrative Code, Part 1 Read More

  • Re: Comments on Proposed Decision Memorandum (CAG-00065R2) Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer Dear Director Syrek Jensen: The Medical Imaging & Technology Alliance (MITA) appreciates this opportunity to submit comments to express its serious concerns with the referenced proposed decision memorandum on the Centers for Medicare & Medicaid Services (CMS) National Read More

  • Dear Senator Dammeier: The Medical Imaging & Technology Alliance (MITA) is pleased to take this take this opportunity to make recommendations and provide feedback to Senate Bill 5145 and Health Technology Assessments (HTAs). MITA is the leading organization and collective voice of medical imaging equipment and radiopharmaceutical manufacturers, innovators, and product developers. We represent companies Read More

  •   Re:  Comments on CMS-1631-P:  Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016; Proposed Rule Dear Administrator Slavitt: The Medical Imaging & Technology Alliance (MITA) appreciates the opportunity to submit comments on the referenced Centers for Medicare & Medicaid Services (CMS) calendar year Read More

  • The Honorable Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue S.W. Room 445-G Washington, DC 20201 Dear Administrator Slavitt: The Medical Imaging & Technology Alliance (MITA) appreciates the opportunity to submit comments on the referenced Centers for Medicare & Medicaid Read More

  • Dear Representative Blackburn and Representative Rush: As the leading trade association representing the manufacturers of medical imaging devices and radiopharmaceuticals, the Medical Imaging and Technology Alliance (MITA) would like to thank you for introducing H.R. 1151, the USPSTF Transparency and Accountability Act. We applaud you for your dedication to improving transparency and accountability in the Read More

  • Dear Senator Ayotte, Senator Mikulski, Representative Ellmers, and Representative Wasserman Schultz: As the leading trade association representing the manufacturers of medical imaging devices and radiopharmaceuticals, the Medical Imaging and Technology Alliance (MITA) would like to thank you for introducing S. 1926 and H.R. 3339, The Protecting Access to Lifesaving Screenings Act. We applaud you for Read More

  • The Medical Imaging & Technology Alliance (MITA) would like to draw your attention to a recently published study in The Lancet titled “Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-up: a randomised controlled trial.”

  • Dear Ms Kux: On behalf of the members of the Medical Imaging and Technology Alliance (MITA), we thank you for this opportunity to provide comments on FDA’s Prescription Drug User Fee Act (PDUFA). We are pleased the FDA continues to seek broad input, including from industry, during reauthorization of PDUFA. MITA agrees that facilitating an Read More

  • On behalf of the members of the Medical Imaging and Technology Alliance (MITA), we thank you for this opportunity to provide comments on FDA’s Generic Drug User Fee Act (GDUFA). We are pleased that FDA continues to seek input from industry during reauthorization of GDUFA. Promoting an efficient and appropriately funded review agency is in the best interest of the public health and the generic drug industry which supports and promotes public health.



  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More


  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More